GL1X · GenesisL1 explorer

MolNFT v1 · #137181 · protein

Fc fragment of human IGG1 antibody, from nist mab

5VGP · Human Fc fragment with G1F/G0F glycan: “Fc fragment of human IGG1 antibody, from nist mab”. X-ray diffraction, 5 ligands (NAG, MAN, BMA), 3 pockets (best druggability 0.31). MolNFT v1 #137181 on GenesisL1: 3D structure, binding…

PDB
5VGP
Type
protein
Length
418 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Human Fc fragment with G1F/G0F glycan
UniProt
Q6PYX1
Ligands
NAG, MAN, BMA, FUC, GAL
Pockets
3 · best druggability 0.31

Structure

x-ray diffraction · 1 distinct chain · 10% helix, 47% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHuman Fc fragment with G1F/G0F glycanprotein20910% helix, 47% strandQ6PYX1

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 8 copies · chains A, B
  • MAN · alpha-D-mannopyranose · sugar · 4 copies · chains A, B
  • BMA · beta-D-mannopyranose · sugar · 2 copies · chains A, B
  • FUC · alpha-L-fucopyranose · sugar · 2 copies · chains A, B
  • GAL · beta-D-galactopyranose · sugar · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1670.310.7515empty
2710.300.7318empty
3520.230.7114empty

Interfaces

1 interface between chains.

  • A–B · 1202 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 5VGP · Fc fragment of human IgG1 antibody, from NIST mAb · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.